GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) » Definitions » Market Cap

Henan Lingrui Pharmaceutical Co (SHSE:600285) Market Cap : ¥14,093 Mil (As of Jun. 08, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Henan Lingrui Pharmaceutical Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Henan Lingrui Pharmaceutical Co's share price for the quarter that ended in Mar. 2024 was ¥21.45. Henan Lingrui Pharmaceutical Co's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 567 Mil. Therefore, Henan Lingrui Pharmaceutical Co's market cap for the quarter that ended in Mar. 2024 was ¥12,165 Mil.

Henan Lingrui Pharmaceutical Co's quarterly market cap declined from Sep. 2023 (¥10,158 Mil) to Dec. 2023 (¥9,704 Mil) but then increased from Dec. 2023 (¥9,704 Mil) to Mar. 2024 (¥12,165 Mil).

Henan Lingrui Pharmaceutical Co's annual market cap declined from Dec. 2021 (¥8,971 Mil) to Dec. 2022 (¥7,400 Mil) but then increased from Dec. 2022 (¥7,400 Mil) to Dec. 2023 (¥9,704 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Henan Lingrui Pharmaceutical Co's Enterprise Value for Today is ¥12,603 Mil.


Henan Lingrui Pharmaceutical Co Market Cap Historical Data

The historical data trend for Henan Lingrui Pharmaceutical Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Henan Lingrui Pharmaceutical Co Market Cap Chart

Henan Lingrui Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,621.31 4,809.34 8,970.59 7,399.67 9,703.83

Henan Lingrui Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8,798.82 9,110.84 10,157.55 9,703.83 12,165.15

Competitive Comparison of Henan Lingrui Pharmaceutical Co's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Henan Lingrui Pharmaceutical Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Henan Lingrui Pharmaceutical Co's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Henan Lingrui Pharmaceutical Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Henan Lingrui Pharmaceutical Co's Market Cap falls into.



Henan Lingrui Pharmaceutical Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Henan Lingrui Pharmaceutical Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=¥17.11*567.144
=¥9,704

Henan Lingrui Pharmaceutical Co's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=¥21.45*567.14
=¥12,165

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Henan Lingrui Pharmaceutical Co  (SHSE:600285) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Henan Lingrui Pharmaceutical Co Market Cap Related Terms

Thank you for viewing the detailed overview of Henan Lingrui Pharmaceutical Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Henan Lingrui Pharmaceutical Co (SHSE:600285) Business Description

Traded in Other Exchanges
N/A
Address
No. 59 Jiefang Chengguan Road, Xinxian, Xinyang, Henan, CHN, 465550
Henan Lingrui Pharmaceutical Co Ltd is a Chinese company engaged in the development, production, and distribution of pharmaceuticals. The Company's products include tablets, capsules, injections and other medicines.
Executives
Wu Xi Zhen Director
Li Jin Supervisors
Ye Qiang senior management
Chen Yan Directors, senior managers
Wu Hui Bin senior management
Yu Peng Director
Zhao Zhi Jun Director
Li Lei senior management
Feng Guo Xin Directors, senior managers
Pan Zi Run Director
Xiong Wei Zheng Director
Tang Wei Supervisors
Cheng Jian Jun Director
Zhang Jun Bing Director
Xia Hui senior management

Henan Lingrui Pharmaceutical Co (SHSE:600285) Headlines

No Headlines